Endonovo Therapeutics, Inc.

OTCPK:ENDV Stock Report

Market Cap: US$317.5k

Endonovo Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of ENDV?
Owner TypeNumber of SharesOwnership Percentage
Institutions600.0000151%
Individual Insiders78,731,65619.8%
General Public318,096,22980.2%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 24.5%.


Top Shareholders

Top 4 shareholders own 19.84% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.4%
Alan Collier
45,031,219US$36.0k0%no data
5.08%
James Greenland
20,175,000US$16.1k0%no data
3.41%
Michael Mann
13,525,437US$10.8k0%no data
0.00002%
Family CFO Inc.
60US$0.060%no data